Who are SymBio Pharmaceuticals's investors?

SymBio Pharmaceuticals's investors include DBJ Capital, Nippon Venture Capital, SMBC Venture Capital, TNP Partners Corporation.

SymBio Pharmaceuticals

4 known investors

Find your way into SymBio Pharmaceuticals

SymBio Pharmaceuticals develops and delivers prescription pharmaceuticals, providing product information on its medical drugs to healthcare professionals in Japan.

Biotech Healthtech

Investors · 4

DBJ CapitalTokyo · $2.7M – $354M

Nippon Venture CapitalTokyo · $1.5M – $269M

SMBC Venture CapitalTokyo · $2.3M – $269Mvia Hiroya Ota · inferred

TNP Partners CorporationYokohama

In the news

SymBio’s First-Half Loss Deepens as Equity Turns Negative - TipRanks.comtipranks.com · Aug 2026

SymBio Pharmaceuticals Limited announced that it expects to receive ¥600 million in funding from Cantor Fitzgerald Europe -December 24, 2024 | MarketScreenermarketscreener.com · Dec 2024

SymBio Pharmaceuticals Successfully Completes JPY2.0 Billion (USD24 Million) Series E Private Placement | Fierce Biotechfiercebiotech.com · Feb 2011

Frequently asked questions

What does SymBio Pharmaceuticals do?: SymBio Pharmaceuticals develops and delivers prescription pharmaceuticals, providing product information on its medical drugs to healthcare professionals in Japan.
Who are SymBio Pharmaceuticals's investors?: SymBio Pharmaceuticals's investors include DBJ Capital, Nippon Venture Capital, SMBC Venture Capital, TNP Partners Corporation.